Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
73,943,049
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
42,232,957
-
Shares change
-
-2,042,794
-
Total reported value, excl. options
-
$145,284,060
-
Value change
-
+$679,387
-
Put/Call ratio
-
0%
-
Number of buys
-
47
-
Number of sells
-
-45
-
Price
-
$3.44
Significant Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q2 2025
121 filings reported holding CATX - Perspective Therapeutics, Inc. - COMMON STOCK as of Q2 2025.
Perspective Therapeutics, Inc. - COMMON STOCK (CATX) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,232,957 shares
of 73,943,049 outstanding shares and own 57.12% of the company stock.
Largest 10 shareholders include FMR LLC (11,102,770 shares), BlackRock, Inc. (4,294,151 shares), VANGUARD GROUP INC (3,274,333 shares), MILLENNIUM MANAGEMENT LLC (2,593,599 shares), Nuveen, LLC (2,297,314 shares), Avidity Partners Management LP (1,858,596 shares), MORGAN STANLEY (1,623,388 shares), Nicholson Wealth Management Group, LLC (1,614,283 shares), GEODE CAPITAL MANAGEMENT, LLC (1,382,814 shares), and STATE STREET CORP (1,088,853 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.